Biocon Share Price Prediction for Tomorrow 5 June 2026: F&O Levels and Technical Outlook

June 4, 2026
Posted by: Kunal Singla
Category: News

Biocon Rs 416.05 (+0.87%), high Rs 419.50, low Rs 406.05 on 4 Jun. Support Rs 406, resistance Rs 422. Cautiously Bullish. RBI MPC 10 AM.

The Biocon prediction for tomorrow 5 June 2026 is Cautiously Bullish as the stock closed at Rs 416.05 (+0.87%) on 4 June 2026, gaining from Rs 412.45. The Biocon prediction for tomorrow is shaped by Biocon gained +0.87% today as pharma sector showed defensive characteristics and Biocon Biologics US biosimilar pipeline continues to attract institutional interest. Additionally, the RBI MPC policy announcement at 10 AM on 5 June 2026 will provide broad market direction that influences all Nifty-listed stocks including Biocon.

Ankit Jaiswal, Senior Research Analyst at Univest, and Kunal Singla, Associate Director at Univest, analyse the F&O data, technical levels and catalysts for the Biocon prediction for tomorrow 5 June 2026.

Click Here – Get Free Investment Predictions

Table of Contents

Biocon Share Price Data for 5 June 2026

Parameter	Value
CMP (4 June 2026)	Rs 416.05
Previous Close	Rs 412.45
Change	+0.87%
Session High	Rs 419.50
Session Low	Rs 406.05
Volume	24.93 L shares
Sector	Pharma/Biotech
Support 1	Rs 406
Support 2	Rs 398
Resistance 1	Rs 422
Resistance 2	Rs 430
Trend	Cautiously Bullish

3 Stocks Building Serious Momentum Right Now

When Univest analysts identify high-conviction stock opportunities, investors pay attention.

Discover stocks investors are actively accumulating
High-conviction opportunities backed by research
Designed for the next phase of market growth

See the Stocks →

Biocon Prediction for Tomorrow: Technical Analysis

Ankit Jaiswal, Senior Research Analyst at Univest, observes that the Biocon prediction for tomorrow is anchored at the Rs 406 support zone. He notes that Biocon gained +0.87% today as pharma sector showed defensive characteristics and Biocon Biologics US biosimilar pipeline continues to attract institutional interest. A sustained hold above Rs 406 and a break above Rs 422 with volume would confirm the Cautiously Bullish thesis for the Biocon prediction for tomorrow.

Kunal Singla, Associate Director at Univest, flags that the Biocon prediction for tomorrow is additionally influenced by the RBI MPC decision at 10 AM on 5 June. The RBI MPC announcement at 10 AM on 5 June will provide broad market direction that will influence trading in this stock. He advises waiting for the first 15-minute candle confirmation post-RBI before entering directional positions in the Biocon prediction for tomorrow.

Biocon Futures and Options Analysis for 5 June 2026

Biocon F&O shows OI near Rs 406-410 Put and Rs 420-422 Call; today’s +0.87% recovery from recent lows is a positive signal for prediction tomorrow. Pharma sector’s defensive nature makes Biocon a relative safe haven if RBI creates broader market volatility. Ankit Jaiswal notes that the Biocon F&O range for the near-term expiry is between Rs 406 (max Put OI support) and Rs 422 (max Call OI resistance) for the prediction for tomorrow.

Check the Univest Screener for live data

Key Drivers for Biocon Prediction for Tomorrow

Biocon gained +0.87% today as pharma sector showed defensive characteristics and Biocon Biologics US biosimilar pipeline continues to attract institutional interest. Nifty 50 closed at 23,416.55 (++0.47%) today with VIX declining to 15.89 (-2.39%), providing a broadly supportive backdrop for the Biocon prediction for tomorrow. DII net buying of Rs +5,740.89 Cr on 3 June remains the key support cushion.

Risks to Biocon Prediction for Tomorrow

Biocon Biologics execution risk and regulatory hurdles for US biosimilar approvals is the primary risk for the Biocon prediction for tomorrow.
FII selling pressure (net Rs -5,616.56 Cr on 3 June) remains a headwind.
A hawkish RBI surprise at 10 AM on 5 June could negatively impact market sentiment.
A Nifty 50 breakdown below 23,300 would drag most index stocks lower.

Conclusion

The Biocon prediction for tomorrow 5 June 2026 is Cautiously Bullish, with Rs 406 as the key support and Rs 422 as the critical resistance. Biocon gained +0.87% today as pharma sector showed defensive characteristics and Biocon Biologics US biosimilar pipeline continues to attract institutional interest. Ankit Jaiswal and Kunal Singla both recommend strict stop-loss discipline given the RBI event risk at 10 AM and elevated FII selling environment. Wait for the RBI announcement before taking large directional positions in the Biocon prediction for tomorrow.

Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice.

Disclaimer: The securities quoted, if any, are for illustration purposes only and are not recommendatory. This article is for educational purposes only and shall not be considered as investment advice or a recommendation by Univest (Uniresearch Global Pvt Ltd, SEBI Registered Research Analyst INH000013776). Investments in the securities market are subject to market risks. Read all related documents carefully before investing. Registration granted by SEBI in no way guarantees the performance of the intermediary or provides any assurance of returns to investors. Past performance is not indicative of future results.

Frequently Asked Questions

What is the Biocon prediction for tomorrow 5 June 2026?

Ans. The Biocon prediction for tomorrow 5 June 2026 is Cautiously Bullish. CMP is Rs 416.05 (+0.87% on 4 June). Support is Rs 406 and resistance is Rs 422. Biocon gained +0.87% today as pharma sector showed defensive characteristics and Biocon Biologics US biosimilar pipeline continues to attract institutional interest.

What are Biocon support and resistance levels for 5 June 2026?

Ans. Support 1: Rs 406. Support 2: Rs 398. Resistance 1: Rs 422. Resistance 2: Rs 430. A close above Rs 422 would confirm a bullish trend for Biocon prediction for tomorrow.

What is the Biocon F&O outlook for 5 June 2026?

Ans. Biocon F&O shows OI near Rs 406-410 Put and Rs 420-422 Call; today’s +0.87% recovery from recent lows is a positive signal for prediction tomorrow. The Biocon prediction for tomorrow is therefore range-bound between Rs 406 and Rs 422 for near-term expiry traders.

What is the key driver for Biocon prediction for tomorrow?

Ans. Biocon gained +0.87% today as pharma sector showed defensive characteristics and Biocon Biologics US biosimilar pipeline continues to attract institutional interest. This is the primary catalyst shaping the Biocon prediction for tomorrow 5 June 2026 alongside broad Nifty 50 direction.

What is the trend for Biocon for 5 June 2026?

Ans. The trend for Biocon prediction for tomorrow is Cautiously Bullish. The stock closed at Rs 416.05 on 4 June 2026 gaining from Rs 412.45. Biocon Biologics execution risk and regulatory hurdles for US biosimilar approvals is the primary risk to monitor.

How does the RBI MPC decision affect Biocon prediction for tomorrow?

Ans. The RBI MPC announcement at 10 AM on 5 June will provide broad market direction that will influence trading in this stock. Ankit Jaiswal and Kunal Singla both advise waiting for the RBI announcement before taking large directional positions in Biocon for the prediction for tomorrow.

Should traders go long or short on Biocon tomorrow?

Ans. This article is for educational purposes only and does not constitute investment advice. Wait for confirmation above Rs 422 before longs, and use Rs 406 as a stop reference. SEBI advisory: Consult a registered financial advisor before trading Biocon.

What is the key risk for Biocon on 5 June 2026?

Ans. The primary risk for the Biocon prediction for tomorrow is Biocon Biologics execution risk and regulatory hurdles for US biosimilar approvals. Additional risks include broader Nifty 50 weakness, elevated FII selling, and elevated VIX. Use strict stop losses.

Download the Univest iOS App or Univest Android App to track Biocon live price and get daily F&O predictions.

News

Author: Kunal Singla

Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.